Aurora Cannabis Added to TSX Composite Index

EDMONTON, March 12, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that the Company, effective Monday March 19, 2018, will be added to the S&P/TSX Composite Index, the primary gauge for Canadian-based, Toronto Stock Exchange listed companies. 

The S&P/TSX Composite Index consists of the largest Canadian companies by market capitalization and liquidity. Inclusion in the index broadens a companys addressable institutional investor universe, including index tracker funds and similar vehicles.

“Inclusion in the index just over two years after commencing commercial operations is a reflection of our exceptional pace of growth and shareholder value creation, and a testament to the Aurora Standard, which represents excellence in execution and customer care,” said Terry Booth, CEO. “This latest milestone will further expand our retail and institutional investor audience and further enhance Auroras liquidity, as we continue to execute diligently on our global expansion strategy.”

Aurora also announced today that Joseph del Moral has resigned his position as Director of the Company to pursue a non-cannabis related opportunity. Mr. del Moral, who also resigned from his position as CEO of CanvasRx, will continue to assist both Aurora and CanvasRx during a transitionary period, and will remain available to the Company as an advisor.

“We are sad to see Joseph leave but are grateful for the important role he has played in the development of Aurora, and are pleased that he has agreed to continue supporting Aurora as an advisor,” said Terry Booth. “We wish Joseph great success with his new venture.”

Auroras wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canadas Access to Cannabis for Medical Purposes Regulations (“ACMPR”). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, known as “Aurora Mountain”, and a second 40,000 square foot high-technology production facility known as “Aurora Vie” in Pointe-Claire, Quebec on Montreals West Island. In January 2018, Auroras 800,000 square foot flagship cultivation facility, Aurora Sky, located at the Edmonton International Airport, was licensed. Once at full capacity, Aurora Sky is expected to produce over 100,000 kg per annum of cannabis.  Aurora is completing a fourth facility in Lachute, Quebec utilizing its wholly owned subsidiary Aurora Larssen Projects Ltd.

Aurora also owns Berlin-based Pedanios, the leading wholesale importer, exporter, and distributor of medical cannabis in the European Union. The Company owns 51% of Aurora Nordic, which will be constructing a 1,000,000 square foot hybrid greenhouse in Odense, Denmark. The Company offers further differentiation through its acquisition of BC Northern Lights Ltd. and Urban Cultivator Inc., industry leaders, respectively, in the production and sale of proprietary systems for the safe, efficient and high-yield indoor cultivation of cannabis, and in state-of-the-art indoor gardening appliances for the cultivation of organic microgreens, vegetables and herbs in home and professional kitchens.

Aurora holds a 19.88% ownership interest in Liquor Stores N.A., who intend to develop a cannabis retail network in Western Canada. In addition, the Company holds approximately 17.23% of the issued shares in leading extraction technology company Radient Technologies Inc., and has a strategic investment in Hempco Food and Fiber Inc., with options to increase ownership stake to over 50%. Aurora is also the cornerstone investor in two other licensed producers, with a 22.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis, and a 17.62% stake in Canadian producer The Green Organic Dutchman Ltd., with options to increase to majority ownership.

On behalf of the Boards of Directors,                                    

AURORA CANNABIS INC.                                                   Terry Booth                                                                             CEO                                                                                        

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information: Cam Battley, Chief Corporate Officer, +1.905.864.5525,,; Marc Lakmaaker, Director, Investor Relations and Corporate Development, +1.647.269.5523,

Aurora’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical marijuana pursuant to the Marihuana for Medical Purposes Regulations and operates a 55,200 square foot, expandable, state-of-the-art production facility in Mountain View County, Alberta, Canada. Aurora trades on the Canadian Securities Exchange under the symbol “ACB”.

Aurora’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical marijuana pursuant to the Marihuana for Medical Purposes Regulations and operates a 55,200 square foot, expandable, state-of-the-art production facility in Mountain View County, Alberta, Canada. Aurora trades on the Canadian Securities Exchange under the symbol “ACB”.

The North American Marijuana Index gained almost eight percent last week, following a volatile few days on the market as investors panicked, then retreated over White House threats of tariffs and trade wars. The Index closed out the trading week at 271.67.

Of more immediate concern to growers and cultivators was news that the price of a pound of legal marijuana has steadily decreased over the past 18 months, according to analysts at Cannabis Benchmarks, who track the cannabis U.S. spot price index.

Spot prices are the current market value at which a product can be bought or sold for immediate delivery, reports The Cannabist. According to the 2017 Annual Review and Outlook, published by Cannabis Benchmarks, the decline in marijuana prices are part of a three-year trend. The reports author, Adam Koh, told The Cannabist recently that prices may finally be reaching a bottom.

Its anyones guess exactly where that is, considering the different market structures in the various states, he said in an interview. But I think were getting close (to the bottom).

Because of the state-by-state policies in the U.S., the spot index has various reasons for why prices are dropping. Wildfires in California were a factor, as was a lack of restrictions on Oregon. One thing Koh noted in his interview with The Cannabist that did not affect prices was pressure from the federal government.

Until there is some sort of concrete (federal) enforcement, all the huffing and puffing really doesnt affect the market dynamics on the ground, he remarked. Businesses… cant worry about it until something happens. Theyve been living in this gray area for some years, and so theyre just going to continue doing what theyre doing.

After Cronos Group Inc. (NASDAQ:CRON) (TSX-V:CRON) moved to become the first weed stock to trade in the U.S. publicly, Canadas second-largest cannabis company, Aurora Cannabis Inc. (TSX:ACB) grabbed headlines last week when they said they might be interested in doing the same. Last Saturday, Aurora Executive Cam Battley took to Twitter, replying to a users who asked if the cannabis company would make a move to the Nasdaq.

Well, in Canada we uplisted from CSE to TSXV to TSX. And in the US from OTCQB to OTCQX. So what would be your guess? ;), wrote Battley.

Canopy Growth Corporation (TSX:WEED) reportedly placed a bid last Tuesday for closely held Spanish firm Alcaliber SA, a morphine and thebaine company. Bloomberg stated that the deal, which was still in the works could be valued at about 200 million euros, or  $246 million, to upwards of 275 million euros.

Several companies are said to be bidding on the firm, though Canopy is the frontrunner according to reports. U.K. health-care investor GHO Capital and Spanish investment firm Alantra Partners SA have are also looking into buying the company.

Bloomberg also reported that Aurora won the support needed to acquire CanniMed Therapeutics Inc. (TSX:CMED), with 71 percent of issued and outstanding common shares being tendered. According to the report, it will be the largest takeover in the history of the marijuana industry. The deal originally agreed to in January, sees Aurora paying CAD$1.23 billion (US$950 million) for the rights to CanniMed Therapeutics.

CannTrust Holdings Inc. (TSX:TRST), a licensed producer of medical cannabis under the Health Canada Access to Cannabis for Medical Purposes Regulation program, began trading on the Toronto Stock Exchange on March 5… Emerald Health Therapeutics, Inc. (TSXV:EHT) (OTCQX:EMHTF) and Village Farms International, Inc. (TSX:VFF) (OTCQX:VFFIF) received a Cultivation Licence from Health Canada for their Delta 3 greenhouse operation last week… WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) and Phivida Holdings Inc. (CSE:VIDA) (OTC:PHVAF) signed off a letter of intent, forming a joint venture to develop cannabis-infused beverages.

New Frontier Data reports that national marijuana legalization under a 15 percent tax rate would be a cash-cow for the federal government. Their report is based on current growth, with sales reaching $48 billion by 2020. The full graphic can be seen below:

Posted in Aurora